Vanda Pharmaceuticals announced it will participate in a fireside chat at the B. Riley Securities Mind, Muscle & Vision Summit in Boston on July 16, 2026. This event highlights Vanda's role as a leading biopharmaceutical company focused on innovative therapies for unmet medical needs. The participation offers investors insight into the company's strategies and future outlook. More information about Vanda can be found on their website and social media channels.
Lyft director Janey Whiteside sold 14,220 shares of the company's stock at a price of $17 per share. This transaction reflects a significant insider sale, which investors often watch as a signal of confidence or strategic portfolio management. The sa...
The Global X MSCI Greece ETF (GREK) has delivered a strong 25% return year-to-date, outperforming European and global peers by nearly double. Despite this, it still trades at a 25-40% discount in valuation. GREK's portfolio is heavily weighted toward...
NextPlat Corp posted strong Q2 2026 results with a 21% sequential revenue increase to $11.9 million, driven by growth in higher-margin 340B healthcare pharmacy contracts and a 27% rise in e-commerce sales. The company achieved a record 40% gross marg...
David Tepper's Appaloosa Management nearly doubled its Amazon shares in Q1 2026, making it his largest holding worth about $900 million. Tepper's bet focuses on Amazon's AWS cloud growth and custom silicon business, despite concerns over heavy AI inf...
Wyndham Hotels & Resorts secured the top three positions in USA TODAY's 10Best Readers' Choice Awards for Best Extended Stay Hotel Brand. ECHO Suites Extended Stay by Wyndham was ranked #1, followed by Hawthorn Extended Stay by Wyndham at #2 and Wate...
